序号 |
标题 |
次数 |
作者 |
发布时间 |
75016 |
H2N-PEG8-OH cas:352439-37-3 氨基-八聚乙二醇-羟基 |
113 |
zyl |
2024-12-24 |
75017 |
α,α,α,β-四-[邻(叔丁氧羰丙氨酸)氨基苯基]卟啉H2T(o-BocAla)APP |
180 |
WYQ |
2024-12-24 |
75018 |
HS-PEG8-CH2CH2COOH cas:866889-02-3 巯基-八聚乙二醇-丙酸 |
120 |
zyl |
2024-12-24 |
75019 |
DOTA-PEG-CRGD,大环化合物 |
141 |
kx |
2024-12-24 |
75020 |
NO2-SPDB-sulfo CAS:663598-89-8 |
124 |
h |
2024-12-24 |
75021 |
DOTAP:DOPC:Chol:PEG2000-ATP Liposome (PEGylated),DOTAP:DOPC:Chol:PEG2000-ATP脂质体(聚乙二醇化) |
138 |
axc |
2024-12-24 |
75022 |
Py-ds-dmBut-amido-PEG4-NHS ester |
121 |
h |
2024-12-24 |
75023 |
HO-PEG6-CH2CH2COOH 羟基-六聚乙二醇-丙酸 |
117 |
zyl |
2024-12-24 |
75024 |
Ald-Ph-amido-PEG2 CAS:1061569-06-9 |
81 |
h |
2024-12-24 |
75025 |
DOTA-E-[c(RGDfK)]2,大环化合物 |
87 |
kx |
2024-12-24 |
75026 |
mPEG11-CH2CH2COOtBu的介绍 |
107 |
zyl |
2024-12-24 |
75027 |
Boc-Val-Ala-PAB-PNP CAS:1884578-00-0 |
107 |
h |
2024-12-24 |
75028 |
5,10,15,20-四(4-月桂酰氨基苯基)卟啉(TLAPP) |
130 |
|
2024-12-24 |
75029 |
Amino-PEG8-Boc CAS:756526-06-4 |
114 |
h |
2024-12-24 |
75030 |
DOTAP:Chol:PEG2000-ATP Liposome (PEGylated),DOTAP:Chol:PEG2000-ATP脂质体(聚乙二醇化) |
103 |
axc |
2024-12-24 |
75031 |
Ga-DOTA-FAPI/ANCP-PSMA,大环化合物 |
129 |
kx |
2024-12-24 |
75032 |
5,10,15,20-四(4-甲氧羰基苯基)卟啉(TCMPP) |
128 |
WYQ |
2024-12-24 |
75033 |
N3-PEG4-C2-Pfp ester CAS:1353012-00-6 |
95 |
h |
2024-12-24 |
75034 |
mPEG40-OH cas:1346556-95-3 甲氧基四十聚乙二醇-羟基 |
109 |
zyl |
2024-12-24 |
75035 |
PC:Chol:PEG2000-ATP Liposome (PEGylated),PC:Chol:PEG2000-ATP脂质体(聚乙二醇化) |
142 |
axc |
2024-12-24 |
75036 |
perfluorophenyl 4-(pyridin-2-yldisulfanyl)butanoate ,PDB-PFP,2088570-81-2,ADC试剂 |
106 |
hyy |
2024-12-24 |
75037 |
Ald-Ph-amido-PEG3-C1-Boc CAS:1007215-94-2 |
82 |
h |
2024-12-24 |
75038 |
2 5 8 11-Tetraoxaheptadecane-17-thiol cas:205490-80-8 |
135 |
zyl |
2024-12-24 |
75039 |
72573-82-1,Gd-DOTA,钆特酸,大环化合物 |
116 |
kx |
2024-12-24 |
75040 |
PS:PC:Chol:PEG2000-ATP Liposome (PEGylated),PS:PC:Chol:PEG2000-ATP脂质体(聚乙二醇化) |
174 |
axc |
2024-12-24 |
75041 |
mPEG45-SSG的结构式 |
109 |
zyl |
2024-12-24 |
75042 |
DOTA satoreotide,大环化合物 |
96 |
kx |
2024-12-24 |
75043 |
PS:PC:Chol:PEG2000-ATP Liposome (PEGylated),PS:PC:Chol:PEG2000-ATP脂质体(聚乙二醇化) |
190 |
axc |
2024-12-24 |
75044 |
mPEG62-OH 甲氧基六二聚乙二醇-羟基 |
141 |
zyl |
2024-12-24 |
75045 |
DOTA-甲基四嗪,1610950-41-8,DOTA-多肽分子探针 |
93 |
kx |
2024-12-24 |
75046 |
mPEG45-OH 甲氧基四十五聚乙二醇-羟基 |
124 |
zyl |
2024-12-24 |
75047 |
DOPG:DOPC:Chol:PEG2000-ATP Liposome (PEGylated),DOPG:DOPC:胆固醇:聚乙二醇2000-ATP脂质体(聚乙二醇化) |
223 |
axc |
2024-12-24 |
75048 |
2,5-Dioxo-1-(4-(pyridin-2-yldisulfanyl)butanoyloxy)pyrrolidine-3-sulfonic acid,SPDB-sulfo,1628113-16-5,抗体- 药物偶联物 |
84 |
hyy |
2024-12-24 |
75049 |
5-(4-羧基苯基)-10,15,20-四苯基镁卟啉(MgTPPCOOH) |
105 |
WYQ |
2024-12-24 |
75050 |
mPEG1-OCH2CH2COONHS Ester cas:1127247-34-0 |
111 |
zyl |
2024-12-24 |
75051 |
1610950-41-8,DOTA-MeTz,DOTA-甲基四嗪,大环化合物 |
123 |
kx |
2024-12-24 |
75052 |
橙红色固体5,15-二(4-乙炔基苯基)-10,20-二苯基钴卟啉(CoDETPP) |
130 |
WYQ |
2024-12-24 |
75053 |
原卟啉二甲酯钴配合物PPDMECo |
102 |
WYQ |
2024-12-24 |
75054 |
DOPG:胆固醇:聚乙二醇2000-ATP脂质体(聚乙二醇化),DOPG:Chol:PEG2000-ATP Liposome (PEGylated) |
169 |
axc |
2024-12-24 |
75055 |
mPEG15-OCH2CH2COOH的介绍 |
105 |
zyl |
2024-12-24 |
75056 |
127985-74-4,(p-SCN-Bn)-dota,2-[(4-异硫氰基苯基)甲基]-1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸,大环化合物 |
99 |
kx |
2024-12-24 |
75057 |
N-Succinimidyl 4-(2-pyridyldithio)butanoate,SPDB,115088-06-7,ADC试剂 |
115 |
hyy |
2024-12-24 |
75058 |
对照阿仑膦酸盐脂质体(阴离子),Control Alendronate Liposome (Anionic) |
148 |
axc |
2024-12-24 |
75059 |
mPEG44-OCH2COOH的介绍 |
115 |
zyl |
2024-12-24 |
75060 |
5-对-(对羰基苯甲酸)-氨基苯基-10,15,20-三苯基卟啉锌(Ⅱ)Zn(p-CPTPP) |
130 |
WYQ |
2024-12-24 |